Literature DB >> 22689320

Responders to cyclophosphamide: results of a single-centre analysis among systemic sclerosis patients.

M O Becker, A Schohe, K Weinert, D Huscher, U Schneider, G R Burmester, G Riemekasten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689320     DOI: 10.1136/annrheumdis-2011-200389

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis.

Authors:  Sabrina Hoa; Sasha Bernatsky; Russell J Steele; Murray Baron; Marie Hudson
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580

Review 2.  Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014.

Authors:  Amber Young; Dinesh Khanna
Journal:  Curr Opin Rheumatol       Date:  2015-05       Impact factor: 5.006

Review 3.  Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review.

Authors:  Caterina Vacchi; Marco Sebastiani; Giulia Cassone; Stefania Cerri; Giovanni Della Casa; Carlo Salvarani; Andreina Manfredi
Journal:  J Clin Med       Date:  2020-02-03       Impact factor: 4.241

Review 4.  Current perspectives on the immunopathogenesis of systemic sclerosis.

Authors:  Patrizia Fuschiotti
Journal:  Immunotargets Ther       Date:  2016-04-11

5.  Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.

Authors:  Sabine Adler; Dörte Huscher; Elise Siegert; Yannick Allanore; László Czirják; Francesco DelGaldo; Christopher P Denton; Oliver Distler; Marc Frerix; Marco Matucci-Cerinic; Ulf Mueller-Ladner; Ingo-Helmut Tarner; Gabriele Valentini; Ulrich A Walker; Peter M Villiger; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2018-01-30       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.